Rodrigo Ruiz-Soto

LigaChem Biosciences · AntibodyChem Biosciences

Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.

Registry trials as an overall official

all conditions, ClinicalTrials.gov

NIH grants tied to them

NIH RePORTER

Trial papers

PubMed author-name match

Trials

Studies that name Rodrigo Ruiz-Soto as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 21:20 UTC. Open this list on ClinicalTrials.gov

Ph1/Ph2
NCT07460375 · A Study to Evaluate Claudin 18.2-Directed ADC LCB02A in Advanced Solid Tumors
LigaChem Biosciences, Inc. · recruiting · Advanced Solid Tumors
Ph1
NCT06774963 · A Phase 1 Study of LNCB74 in Advanced Solid Tumors
LigaChem Biosciences, Inc. · recruiting · Ovarian Cancer, Breast Cancer, Endometrial Cancer · study director
Ph1/Ph2
NCT05941507 · A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
LigaChem Biosciences, Inc. · recruiting · Advanced Solid Tumors · study director

Grants

NIH projects from RePORTER, fetched 2026-11-11 21:20 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

Most cited trial papers

Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 21:20 UTC. The ranking covers the 200 most relevant of 22 PubMed records, and a shared surname and initials can bring in a namesake. All 22 on PubMed